Cereno Scientific AB Logo

Cereno Scientific AB

Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.

CRNO | ST

Overview

Corporate Details

ISIN(s):
SE0008241541 (+3 more)
LEI:
549300VX8KTMYDS6NM84
Country:
Sweden
Address:
BioVentureHub, 431 83 Mölndal
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cereno Scientific AB is a clinical-stage biotechnology company focused on developing innovative, disease-modifying treatments for rare cardiovascular and pulmonary diseases. The company's pipeline includes drug candidates in both clinical and preclinical phases. Its clinical portfolio utilizes epigenetic modulation through an HDACi (histone deacetylase inhibitor) platform. A key preclinical asset, CS585, is a novel prostacyclin (IP) receptor agonist. Cereno's strategy targets diseases with significant unmet medical needs, aiming to provide high treatment value to patients while leveraging a business model that allows for potentially shorter development timelines and accelerated market entry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cereno Scientific AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-16 Sten Sörensen Other Other 866,665 86,666.50 SEK
2024-11-25 Security Holding Sverige AB Other Buy 20,000 99,800.00 SEK

Peer Companies

Company Country Ticker View
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan 4771
FRIENDLY CORPORATION Logo
Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.
Japan 8209
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan 4881
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan 9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan 2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea 095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea 389030
genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France ALGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.